Assembly Biosciences (ASMB) Operating Leases (2019 - 2026)

Assembly Biosciences' Operating Leases history runs 8 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• In Q1 2026, Operating Leases fell 23.69% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (down 23.69% YoY), while the FY2025 annual figure was $2.1 million, down 21.65% from the prior year.
• Operating Leases was $1.9 million for Q1 2026 at Assembly Biosciences, down from $2.1 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $2.6 million in Q4 2024 to a low of $50000.0 in Q3 2023.
• Historically, Operating Leases has averaged $1.3 million across 5 years, with a median of $1.1 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Operating Leases sank 96.96% in 2022, then surged 1853.1% in 2025.
• A 5-year view of Operating Leases shows it stood at $101000.0 in 2022, then soared by 1010.89% to $1.1 million in 2023, then soared by 134.22% to $2.6 million in 2024, then dropped by 21.65% to $2.1 million in 2025, then fell by 7.67% to $1.9 million in 2026.
• The last three Operating Leases figures came in at $1.9 million (Q1 2026), $2.1 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.